No Benefit of Anti-inflammatory Strategy in Acute Myocarditis
A short course of the interleukin-1 receptor antagonist, anakinra, appeared safe but did not reduce complications of acute myocarditis in the ARAMIS trial.
https://www.medscape.com/viewarticle/996176? #AntiInflammatory #myocarditis #interleukin1 #anakinra #ARAMIS